Geyser Brands (TSX.V: GYSR) announced key appointments
to its leadership team recently, including the addition of Dr. Bin Huang to the
company’s board of directors (http://ibn.fm/ElFjT).
An article discussing the company reads, “Joining the board of directors is Dr.
Bin Huang, a seasoned, life-sciences executive with experience in strategy and
new business development, financing and public markets, corporate governance
and operations management in North America and Asia. She most recently served
as CEO of Emerald Health Therapeutics Inc. and has held senior-management roles
in both startups and Fortune 500 corporations. Huang holds a PhD in plant cell
biology from the University of East Anglia, UK, and an MBA from the University
of Toronto, Canada. . . . ‘The board of directors are extremely pleased that
Dr. Huang has accepted our offer to join our growing company,’ Brad Kersch,
chairman of the board, stated in a news release. ‘Her depth of experience in
life sciences and her leadership demonstrated in the corporate world,
particularly in the cannabis industry, will provide unparalleled value and
oversight to the company’s development.’”
To view the full article, visit http://ibn.fm/QdKPk
About Geyser Brands Inc.
Geyser Brands builds health-based, hemp-CBD consumer
products in the nutraceutical, cosmetics, food and beverage and pet sectors
worldwide. R&D investment in NanoFusion, a proprietary all-natural
nanotechnology, delivers topical, cream, beverages and baked goods, oil, and
tincture formulations with superior bioavailability and water solubility.
Geyser Brands owns a Health Canada licensed producer (“LP”) in Port Coquitlam,
British Columbia, that holds cultivation and processing licenses and is
anticipating its R&D and sales licenses. The company is exclusively
focusing on leveraging these assets to provide the regulatory infrastructure
for its global brands and distribution strategy, acquiring hemp- and
plant-based brands and infusing them with new CBD product lines in
jurisdictions where the therapeutic ingredient is legal. The company’s
proprietary NanoFusion technology surrounds oils and solves for the
insolubility of CBD. Geyser Brands will utilize both of its GM-licensed
facilities in British Columbia for the manufacturing and international
distribution of its hemp- and CBD-based products. For more information, visit
the company’s website at www.GeyserBrands.com.
NOTE TO INVESTORS: The latest news and updates
relating to GYSR are available in the company’s newsroom at http://ibn.fm/GYSR
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment